Stiripentol (diacomit(R)) for refractory epilepsy patients with autoimmune encephalitis
Not Applicable
Recruiting
- Conditions
- refractory epilepsy
- Registration Number
- JPRN-UMIN000023741
- Lead Sponsor
- agoya City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
patients allergic to component of this drug pregnant or possibly pregnant women patients chief or sub investigator diagnose inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method neurological sign: continuous observation about presence or absence, frequency, and duration of seizures after medication
- Secondary Outcome Measures
Name Time Method electroencephalogram(EEG): continuous observation about presence or absence of epileptic discharges in simple EEG fitted all the time, and 10-20 EEG at every two weeks after medication